X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Biocon Ltd with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs TEVA PHARMA (Israel) - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    TEVA PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-18
TEVA PHARMA
Dec-13
BIOCON /
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,1882,906-   
Low Rs3052,525-   
Sales per share (Unadj.) Rs68.71,668.0-  
Earnings per share (Unadj.) Rs7.6104.2-  
Cash flow per share (Unadj.) Rs14.0239.0-  
Dividends per share (Unadj.) Rs1.0091.22-  
Dividend yield (eoy) %0.13.4 4.0%  
Book value per share (Unadj.) Rs86.31,852.8-  
Shares outstanding (eoy) m600.00848.00-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.91.6 667.2%   
Avg P/E ratio x98.926.1 379.3%  
P/CF ratio (eoy) x53.411.4 470.3%  
Price / Book Value ratio x8.61.5 589.9%  
Dividend payout %13.287.5 15.1%   
Avg Mkt Cap Rs m447,9002,302,803 19.5%   
No. of employees `0006.144.9 13.7%   
Total wages/salary Rs m9,3110-   
Avg. sales/employee Rs Th6,705.831,471.0 21.3%   
Avg. wages/employee Rs Th1,514.20-   
Avg. net profit/employee Rs Th736.91,966.0 37.5%   
INCOME DATA
Net Sales Rs m41,2341,414,464 2.9%  
Other income Rs m2,0620-   
Total revenues Rs m43,2961,414,464 3.1%   
Gross profit Rs m8,291387,352 2.1%  
Depreciation Rs m3,851114,332 3.4%   
Interest Rs m61527,782 2.2%   
Profit before tax Rs m5,887245,237 2.4%   
Minority Interest Rs m2131,114 19.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-160,985 0.0%   
Tax Rs m1,569-2,994 -52.4%   
Profit after tax Rs m4,53188,360 5.1%  
Gross profit margin %20.127.4 73.4%  
Effective tax rate %26.7-1.2 -2,183.0%   
Net profit margin %11.06.2 175.9%  
BALANCE SHEET DATA
Current assets Rs m41,486955,324 4.3%   
Current liabilities Rs m21,413833,123 2.6%   
Net working cap to sales %48.78.6 563.5%  
Current ratio x1.91.1 169.0%  
Inventory Days Days6491 70.4%  
Debtors Days Days9496 98.2%  
Net fixed assets Rs m50,661461,995 11.0%   
Share capital Rs m3,0003,482 86.2%   
"Free" reserves Rs m48,8080-   
Net worth Rs m51,8081,571,201 3.3%   
Long term debt Rs m17,898723,247 2.5%   
Total assets Rs m99,8973,232,503 3.1%  
Interest coverage x10.69.8 107.6%   
Debt to equity ratio x0.30.5 75.1%  
Sales to assets ratio x0.40.4 94.3%   
Return on assets %5.23.6 143.4%  
Return on equity %8.75.6 155.5%  
Return on capital %9.64.9 195.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,7100-   
CASH FLOW
From Operations Rs m6,621225,392 2.9%  
From Investments Rs m-6,840-79,866 8.6%  
From Financial Activity Rs m-2,397-270,373 0.9%  
Net Cashflow Rs m-2,612-124,847 2.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 69.63 Rs / USD

Compare BIOCON With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare BIOCON With: ABBOTT INDIA  FDC LTD.  AUROBINDO PHARMA  IPCA LABS  PANACEA BIOTECH  



Today's Market

Sensex Ends 140 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets ended their day on a positive note today ahead of counting of Lok Sabha Election 2019 to be done tomorrow.

Related Views On News

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


May 22, 2019 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS